Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q1 FY2021 Earnings Presentation
22 slides from Zota Health Care's earnings presentation, Sep 9, 2020
Slide 1: Cover letter to NSE: Investor Presentation
A zoto' healthcare ltd. September 09,2A20 To, The Manager Listing Department, The National Stock Exchange of tndia limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400051 t Dear Sir/Madam, Trading Symbol: ZOTA Sub: lnvestor Presentation Ref: Regulation 30 of SEBI {Listing obtigatio
Slide 2: Q4 & FY20 / Q1FY21 Performance Highlights
Q4&FY20 Q1FY21 PPerformance E R F O R M A N C E HHighlights IGHLIGHTS September J U N E 2 0 2 0 2020
Slide 3: Safe Harbor
Safe Harbor This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer d
Slide 4: Table Of Contents
Table Of Contents 1 Result Highlights 2 Davaindia 3 Industry Snapshot 4 Financial Summary 3
Slide 5: Qtr- Result Highlights
A zoid Qtr- Result Highlights
Slide 6: Consol Quarterly Financial Highlights
Consol Quarterly Financial Highlights Q-o-Q 2308.00 72.7 33.66% 151 1754.96 50.84 115.19 32.90% Q1-FY21 Q4-FY20 Q1-FY21 Q4-FY20 Q1-FY21 Q4-FY20 Q1-FY21 Q4-FY20 Revenues (Rs Lakhs) Gross Profit (%) Operating Profit (Rs Lakhs) PAT (Rs Lakhs) Y-o-Y 33.66% 2168.19 56.18 115.19 1754.96 85.3 30.84% 50.84
Slide 7: Revenue Break up – Quarterly
Revenue Break up – Quarterly Domestic Sales Dava India Sales 370.00 325.00 1475.90 1446.50 230.40 1056.23 Q1-FY20 Q4-FY20 Q1-FY21 Q1-FY20 Q4-FY20 Q1-FY21 Export Sales (SEZ) 536.40 461.80 328.73 Q1-FY20 Q4-FY20 Q1-FY21 6
Slide 8: Consol Profit & Loss Statement - Quarterly
Consol Profit & Loss Statement - Quarterly Particulars (Rs Lakhs) Q1FY21 Q1FY20 YoY % QoQ % Q4FY20 Export Sales (SEZ) 328.73 461.80 -29% -14% 536.4 Dava India Sales 370.00 230.40 61% -29% 325.0 Domestic Sales 1056.23 1475.90 -28% 2% 1,446.5 Revenues from Operations 1,754.96 2168.19 -19% -24% 2,308.0
Slide 9: Management Commentary
Management Commentary • COVID-19 outbreak throughout the globe resulted slowdown and disturbance of economic activities. Due to nationwide lockdown, company's operations were impacted. During the quarter company's business remained totally shut up till April 16, 2020 and accordingly Company’s Q1FY21
Slide 10: Management Commentary: Domestic Operations and Exports
Management Commentary Domestic Operations • COVID-19 outbreak has caused the nationwide lockdown and impacted the business operations in the country. Effect of the same has been seen in Company’s business, Domestic Revenues in Q1FY21 were down by 28% YoY. • The company has registered the domestic re
Slide 11: Davaindia Generic Pharmacy
healthcare Itd. GY davaindia’ GENERIC PHARMACY
Slide 12: Davaindia Key Figures
Davaindia Key Figures SKU’s Sales % 1333 1338 1353 1250 1310 1150 OTC/Cosmetics 17.7% 1100 Cardiac & Diabetic 1000 1050 32.3% Segments 0 Bill (%) 36% Avg Wallet Spends 32 (Rs) 0 10 20 30 40 Q1-FY19 Q2-FY19 Q3-FY19 Q4-FY19 Q1-FY20 Q2-FY20 Q3-FY20 Q4-FY20 Q1-FY21 Stores rolled-out 45 39 33 29 32 31 28
Slide 13: Davaindia Key Figures
Davaindia Key Figures Average Wallet Spend No. of Customers Served 159 164 152 338415 132 136 126 109 113 116 259022 267030 275520 231100 221975 90000 90400 83925 Q1-FY19 Q2-FY19 Q3-FY19 Q4-FY19 Q1-FY20 Q2-FY20 Q3-FY20 Q4-FY20 Q1-FY21 Q1-FY19 Q2-FY19 Q3-FY19 Q4-FY19 Q1-FY20 Q2-FY20 Q3-FY20 Q4-FY20 Q
Slide 14: Davaindia catered 3.38 lakh customers during the quarter
• During the quarter Davaindia has catered 3.38 lakhs customers and impact of the same can be seen on revenue side, Davaindia has registered robust growth in Q1FY21 at 61% YoY • Davaindia has witnessed turnaround of patients to generic medicines from the branded counterparts; Till Q1FY21 Davaindia h
Slide 15: 14
14
Slide 16: Davaindia Footprints
Davaindia Footprints HIMACHAL PRADESH (2) PUNJAB (1) HARYANA (8) NEW DELHI (9) Yamunanagar, Kurukshetra, Bhiwani, Hisar,Faridabad, UTTARAKHAND (2) Yamunanagar Dehradun, Araghar RAJASTHAN (10) Jaipur, Jodhpur, Sikar, Shri Ganganagar, Nagpur, UTTAR PRADESH (25) Bharatpur Jhansi,Varanasi,,Amroha,Luckno
Slide 17: Industry Snapshot
Industry Snapshot
Slide 18: Jan Aushadhi Stores and Branded vs Generic mix of Indian pharma market
4 pillars to drive healthcare Branded and generic mix of Indian pharma market Jan Aushadhi Store s A key initiative against the high priced selling medicines in the market 17
Slide 19: Financial Summary
ml ae Financial Summary A zoid
Slide 20: Profit & Loss Statement
Profit & Loss Statement Particulars (INR Lakhs) FY15 FY16 FY17 FY18 FY19 FY20 Q1FY21 Income from Operations 5,646.3 6,473.3 7,158.0 7,785.2 8,562.9 9,511.3 1,754.96 Other Income 1.4 7.7 5.6 151.9 154.5 151.3 22.82 Total Income 5,647.8 6,481.0 7,163.6 7,937.0 8,717.4 9,662.6 1,777.78 Operating Expens
Slide 21: Balance Sheet & Key Ratios
Balance Sheet & Key Ratios Particulars (INR Lakhs) FY14 FY15 FY16 FY17 FY18 FY19 FY20 Share capital 1,196.9 1,436.3 1,436.3 1,436.3 1,754.3 1,754.3 2,456.0 Reserves and Surplus 384.2 395.7 707.8 1,262.0 5,223.4 5,138.2 4,426.9 Non-current liabilities 521.3 548.7 272.7 466.8 64.7 87.1 105.3 Current l
Slide 22: Thank You
Contact Information Mr. Himanshu Zota / Mr. Ashvin Variya "ZOTA HOUSE", 2/896, Hira Modi Street, Sagrampura, Surat-395 002(Gujarat) cszota@zotahealthcare.com www.zotahealthcare.com Thank You